Evaluation of the urethral α/β ratio and tissue repair half-time for iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy-Reference-Cited by-同舟云学术

Evaluation of the urethral α/β ratio and tissue repair half-time for iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy

Published:2020-05 Issue:3 Volume:19 Page:290-297
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Gocho Toshio,Hori Masakazu,Fukushima Yuuki,Someya Masanori^ORCID,Kitagawa Mio,Hasegawa Tomokazu,Tsuchiya Takaaki,Hareyama Masato,Takagi Masaru^ORCID,Hashimoto Kohei,Masumori Naoya,Sakata Koh-ichi

Funder

Ono Cancer Research Fund

JSPS KAKENHI

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference21 articles.

1. Low-risk prostate cancer;Perez,2018

2. Management of intermediate- and high- risk prostate cancer: what do we know?;Roach,2018

3. Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy;Eriguchi;Brachytherapy,2016

4. Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer;Crook;CMAJ,2001

5. Biologically effective dose (BED) correlation with biochemical control after low-dose rate prostate brachytherapy for clinically low-risk prostate cancer;Edward;Int J Radiat Oncol Biol Phys,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Framework for the Optimization of Simultaneous ThermoBrachyTherapy;Cancers;2022-03-10

2. Synergistic combination of polymer-coated copper and selenium nanoparticles and X-ray induced radiotherapy for improved nursing care of human prostate cancer cells;MATER EXPRESS;2021